Valneva Reports Q1 2021 Financial Results and Business Update
Excellent progress on clinical programs in the first quarter of 2021 for:VLA15, currently the only clinical stage vaccine candidate against...
Valneva
Excellent progress on clinical programs in the first quarter of 2021 for:VLA15, currently the only clinical stage vaccine candidate against...
